Physical Activity Is Associated With Macular Thickness: A Multi-Cohort Observational Study.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
3
3
2023
pubmed:
4
3
2023
medline:
8
3
2023
Statut:
ppublish
Résumé
To assess the association between physical activity and spectral-domain optical coherence tomography (SD-OCT)-measured rates of macular thinning in an adult population with primary open-angle glaucoma. The correlation between accelerometer-measured physical activity and rates of macular ganglion cell-inner plexiform layer (GCIPL) thinning was measured in 735 eyes from 388 participants of the Progression Risk of Glaucoma: RElevant SNPs with Significant Association (PROGRESSA) study. The association between accelerometer-measured physical activity and cross-sectional SD-OCT macular thickness was then assessed in 8862 eyes from 6152 participants available for analysis in the UK Biobank who had SD-OCT, ophthalmic, comorbidity, and demographic data. Greater physical activity was associated with slower rates of macular GCIPL thinning in the PROGRESSA study (beta = 0.07 µm/y/SD; 95% confidence interval [CI], 0.03-0.13; P = 0.003) after adjustment for ophthalmic, demographic and systemic predictors of macular thinning. This association persisted in subanalyses of participants characterized as glaucoma suspects (beta = 0.09 µm/y/SD; 95% CI, 0.03-0.15; P = 0.005). Participants in the upper tertile (greater than 10,524 steps/d) exhibited a 0.22-µm/y slower rate of macular GCIPL thinning than participants in the lower tertile (fewer than 6925 steps/d): -0.40 ± 0.46 µm/y versus -0.62 ± 0.55 µm/y (P = 0.003). Both time spent doing moderate/vigorous activity and mean daily active calories were positively correlated with rate of macular GCIPL thinning (moderate/vigorous activity: beta = 0.06 µm/y/SD; 95% CI, 0.01-0.105; P = 0.018; active calories: beta = 0.06 µm/y/SD; 95% CI, 0.006-0.114; P = 0.032). Analysis among 8862 eyes from the UK Biobank revealed a positive association between physical activity and cross-sectional total macular thickness (beta = 0.8 µm/SD; 95% CI, 0.47-1.14; P < 0.001). These results highlight the potential neuroprotective benefits of exercise on the human retina.
Identifiants
pubmed: 36867133
pii: 2785418
doi: 10.1167/iovs.64.3.11
pmc: PMC9988706
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11Subventions
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Références
Sci Rep. 2019 Dec 6;9(1):18528
pubmed: 31811166
Prev Med. 2016 Jun;87:18-21
pubmed: 26861750
Arch Ophthalmol. 2003 Jun;121(6):785-92
pubmed: 12796248
Ophthalmology. 2019 Aug;126(8):1119-1130
pubmed: 30910584
Nat Genet. 2020 Feb;52(2):160-166
pubmed: 31959993
Clin Epidemiol. 2017 Dec 18;10:1-16
pubmed: 29296097
JAMA Ophthalmol. 2020 Jan 1;138(1):86-94
pubmed: 31774456
Am J Ophthalmol. 2017 Aug;180:29-38
pubmed: 28549846
BMC Public Health. 2016 Jun 16;16:515
pubmed: 27306667
J Med Eng Technol. 2013 Oct;37(7):456-62
pubmed: 24007317
Neurobiol Aging. 2014 Jul;35(7):1722-5
pubmed: 24524967
Physiother Can. 2017;69(2):152-160
pubmed: 28539695
Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S68-76
pubmed: 22157777
Ophthalmology. 2014 Jun;121(6):1220-8
pubmed: 24594095
Ophthalmology. 2019 Jul;126(7):965-966
pubmed: 31229007
Aging Cell. 2016 Dec;15(6):1082-1091
pubmed: 27613664
Ophthalmol Glaucoma. 2020 Sep - Oct;3(5):393-402
pubmed: 32741639
Arch Intern Med. 1998 Jul 27;158(14):1499-505
pubmed: 9679790
Am J Cardiol. 2017 Aug 15;120(4):688-692
pubmed: 28676154
JMIR Mhealth Uhealth. 2018 Aug 09;6(8):e10527
pubmed: 30093371
BMJ Open Sport Exerc Med. 2017 Sep 13;3(1):e000254
pubmed: 29018543
BMJ. 2019 Jun 26;365:l2323
pubmed: 31243014
J Glaucoma. 2009 Aug;18(6):429-36
pubmed: 19680049
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Am J Ophthalmol. 2021 Oct;230:276-284
pubmed: 33992612
Eye (Lond). 2018 Aug;32(8):1296-1303
pubmed: 29610523
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):16
pubmed: 32915981
Ophthalmology. 2016 Apr;123(4):829-40
pubmed: 26746598
BMJ Open. 2019 Jan 29;9(1):e024206
pubmed: 30700478
Ophthalmology. 2021 Jan;128(1):70-77
pubmed: 32615202
Eye (Lond). 2021 Feb;35(2):393-399
pubmed: 32291406
Circulation. 2007 Nov 6;116(19):2110-8
pubmed: 17967770
BMJ Open Sport Exerc Med. 2015 Jul 8;1(1):e000013
pubmed: 27900119
Med Sci Sports Exerc. 2019 Nov;51(11):2251-2256
pubmed: 31107835
Br J Ophthalmol. 2006 Dec;90(12):1461-3
pubmed: 17077116
BMC Public Health. 2016 Dec 3;16(1):1215
pubmed: 27912742
J Epidemiol Community Health. 2012 Dec;66(12):1110-5
pubmed: 22791800
PLoS One. 2020 Apr 28;15(4):e0232420
pubmed: 32343753
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8186-92
pubmed: 21911585
Scand J Med Sci Sports. 2016 Jan;26(1):93-100
pubmed: 25559167
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4733-9
pubmed: 27607419
Nat Methods. 2018 Dec;15(12):1001
pubmed: 30504882
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2856-65
pubmed: 22491403
Ophthalmology. 2019 Jul;126(7):958-964
pubmed: 30315900
Eur J Ophthalmol. 2022 Jul;32(4):2265-2273
pubmed: 34747249
Ophthalmology. 2021 Jan;128(1):58-69
pubmed: 32730956
Br J Ophthalmol. 2016 Oct;100(10):1353-8
pubmed: 26787681
Ophthalmology. 2012 Jun;119(6):1159-66
pubmed: 22386950
Prog Retin Eye Res. 2006 May;25(3):325-53
pubmed: 16716639
PLoS One. 2017 Feb 1;12(2):e0169649
pubmed: 28146576
Ophthalmology. 2012 Dec;119(12):2486-92
pubmed: 22892152
Arch Intern Med. 2009 Oct 26;169(19):1781-7
pubmed: 19858436